Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label single-arm study of etrasimod in adolescents with moderately to severely active ulcerative colitis
jRCT2031230586Recruiting
- Sponsor
- Pfizer
- Start
- May 2024
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of etrasimod in autoimmune colitis, sponsored by Pfizer. Primary endpoint: Clinical remission by Modified Mayo Score at Week 52. Started May 2024; status: recruiting.
02
Drugs
etrasimod
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCT2031230586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230586.